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The S. pombe cytokinesis NDR kinase Sid2 activates
Fin1 NIMA kinase to control mitotic commitment
through Pom1/Wee1
Agnes Grallert1,4, Yvonne Connolly2, Duncan L. Smith2, Viesturs Simanis3 and Iain M. Hagan1,4
Mitotic exit integrates the reversal of the phosphorylation
events initiated by mitotic kinases with a controlled cytokinesis
event that cleaves the cell in two. The mitotic exit network
(MEN) of budding yeast regulates both processes, whereas the
fission yeast equivalent, the septum initiation network (SIN),
controls only the execution of cytokinesis. The components and
architecture of the SIN and MEN are highly conserved1. At
present, it is assumed that the functions of the core SIN–MEN
components are restricted to their characterized roles at the
end of mitosis. We now show that the NDR (nuclear
Dbf2-related) kinase component of the fission yeast SIN,
Sid2–Mob1, acts independently of the other known SIN
components in G2 phase of the cell cycle to control the timing
of mitotic commitment. Sid2–Mob1 promotes mitotic
commitment by directly activating the NIMA (Never In
Mitosis)-related kinase Fin1. Fin1’s activation promotes its own
destruction, thereby making Fin1 activation a transient feature
of G2 phase. This spike of Fin1 activation modulates the
activity of the Pom1/Cdr1/Cdr2 geometry network
towards Wee1.
Schizosaccharomyces pombe contains a single NIMA kinase, Fin1 (ref. 2).
Deletion of fin1+ (fin1.∆) delays mitotic commitment2, indicating that
Fin1 emulates its Aspergillus nidulans counterpart in regulating the G2
to M transition3. We monitored Fin1 levels in cultures in which cell
cycle progression had been synchronized by size selection of small, early
G2 phase, cells. During mitosis, Fin1 levels paralleled the septation
profile, dropping markedly as the septation index decreased (Fig. 1a,
arrow C for cytokinetic decline). Fin1 levels rose sharply once more
at the start of the following G2 phase before rapidly declining again
midway through this G2 phase (Fig. 1a; arrow G2 for G2 phase decline).
Fin1 accumulation/decline is a G2, rather than size-dependent, event
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because it did not occur when cell cycle progression was arrested at
START or early S phase (data not shown).
Ablation of the APC/C had no impact on Fin1 protein levels2
(data not shown); however, Fin1 accumulated in size-selected skp1.A4
cultures following inactivation of the ubiquitous component of all
Cullin-based E3 ubiquitin ligase complexes Skp1 (ref. 4; Fig. 1b).
Substrate recognition by Cullin family E3 ligases is often contingent
on phosphorylation to generate a phospho-degron recognition motif.
Therefore, we investigated whether any kinases associated with either
G2 or septation events influenced Fin1’s stability, starting with Fin1
itself. Fin1 levels were elevated in fin1.KD cells in which Fin1 is
catalytically inactive (Fig. 1c; for characterization of fin1.KD, see
Supplementary Fig. S2a–d) and did not oscillate as synchronized
fin1.KD cultures transited the cell cycle (Fig. 1d). Expression of a
fin1.GFP fusion gene from a heterologous locus (wild-type Fin1
kinase, 27 kDa larger than Fin1.KD) induced fluctuations in the
stability of the Fin1.KD protein that paralleled those of the wild-
type fusion protein in the same cells (Fig. 1e). This ability of Fin1
activity to promote Fin1 destruction in trans probably arises from
direct phosphorylation because Fin1 phosphorylates recombinant
Fin1.KD in vitro (Fig. 1f).
We combined mutations in kinases associated with either G2 or
septation events with cdc25.22. Inactivation of Cdc25 by incubation
at 36 ◦C arrests cell cycle progression at the G2/M boundary, after the
point at which Fin1 destruction is normally triggered. Deficiency in
any kinase that promotes Fin1 destruction during G2 phase would be
expected to elevate Fin1 levels in these arrested cells. Fin1 levels were
markedly elevated in G2-arrested sid2.250 cdc25.22 cells (Fig. 1g). We
therefore used the temperature- and ATP-analogue-sensitive alleles
sid2.250 and sid2.as4 (Supplementary Fig. S2h,i–l) to assess the impact
of Sid2 function on Fin1 stability. In each case, Sid2 inactivation in
early G2 abolished the sharp declines in Fin1 levels that normally occur
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Figure 1 Fin1 kinase is destroyed twice in each cell cycle in a Cullin-, Fin1-
and Sid2-dependent manner. (a,b,d,e,h–j) Fin1 levels were normalized to
those of Cdc2 kinase in the same lane on the same blot and plotted against
time as cells transit the cell cycle (for images of blots see Supplementary
Fig. S1b). (a) Fin1 levels declined at two points in wild type cultures;
mid-G2 (grey arrow G2) and during septation (open arrow C). Destruction
was seen irrespective of whether the culture was maintained at 25 ◦C
throughout the experiment, or shifted to 36 ◦C immediately after size
selection (Supplementary Fig. S4c). (b) Oscillations in Fin1 levels were not
seen after synchronized skp1.A4 cultures were shifted to 36 ◦C immediately
after size selection at 25 ◦C to inactivate Skp1. (c,g) Normalized Fin1
levels in blots of asynchronous or cdc25.22 arrested double-mutant
cultures reveal threefold increases in Fin1 levels in the fin1.K33RN165A
kinase-dead and sid2.250 backgrounds. (d) Fin1 levels did not fluctuate as
fin1.K33RN165A cultures transited a synchronized cell cycle. (e) Strikingly
the levels of both the inactive fin1.K33RN165A protein and the GFP-tagged
wild-type protein oscillate as cells transit the cell cycle when a wild-type
Fin1.GFP fusion protein was constitutively expressed within the same
cells. (f) Fin1 immunoprecipitates from asynchronous cells were employed
in kinase assays that used recombinant Fin1 or casein as substrates.
(g) Left: 210 and 240min refers to the duration of incubation at 36 ◦C to
inactivate and arrest cell cycle progression at the G2/M boundary. Right:
fluorescence-activated cell sorting profiles of DNA content demonstrate
G2 arrest in all strains. (h–j) Assessing the impact of Sid2–Mob1 function
on Fin1 levels in size-selected synchronized cultures. (h,j) sid2.250 and
mob1.E9 cultures were maintained at 25 ◦C during transit through the first
cell division before a portion of the culture was shifted to 36 ◦C to inactivate
the kinase/regulatory subunit. (i) A sid2.as4 culture was split into three
after the first wave of septation was complete (Supplementary Fig. S1c) and
either nothing, methanol or 3-MB-PP1 in methanol was added to a final
concentration of 20 µM at time point 190. Images of blots/gels are shown in
Supplementary Fig. S1.
during G2 phase and mitotic exit (Fig. 1h,i). The sharp increase in Fin1
levels in early G2 phase was also absent in the sid2.250 culture (Fig. 1h),
suggesting that Sid2 activitymay also promote Fin1 production/stability
at this point in the cell cycle. The levels of Fin1 in fin1.KD skp1.A4,
and sid2.as skp1.A4 were identical to those seen in the fin1.KD or
skp1.A4 or sid2.as single mutant backgrounds (Supplementary Fig.
S3a,b). As Sid2 function in the SIN requires association with Mob1,
we assessed Fin1 behaviour in synchronizedmob1.E9 mutant cultures.
Fin1 behaviour inmob1.E9 mirrored that seen in the sid2.250 mutant
background (Fig. 1j).
We studied the changes in Fin1 kinase specific activity in size-selected
synchronized cultures (Fig. 2a and Supplementary Fig. S2b,d). Fin1
activity increased midway through G2 phase, and increased further
after mitotic commitment (40–60min before septation). Addition of
the ATP analogue 3-MB-PP1 to size-selected sid2.as4 skp1.A4 cultures
abolished both the G2 and mitotic enhancement of Fin1 activity,
supporting the view that Sid2 activity in G2 phase of the cell cycle
promotes Fin1 activation (Fig. 2b).
Similarly to its budding yeast counterpart Dbf2, Sid2 targets the
consensus sequence RXXS/T (refs 5,6). The two RXXS/T sequences in
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Figure 2 Sid2 phosphorylation of Fin1 on Ser 377, 526 and 698 promotes
Fin1 activity in G2 phase before a peak of each kinase activity accompanies
mitotic progression. (a,b) Fin1 kinase assays from size-selected cultures
in which His-tagged Fin1.KD was labelled with [γ−32 P]ATP to quantify
activity that is plotted alongside the septation profile. Wild-type (a) and
small G2 sid2.as4 skp1.A4 (b) cells were isolated from a culture grown
at 25 ◦C and immediately shifted to 36 ◦C to inactivate Skp1 (and so
preserve activated Fin1) at t =0. The culture was split in two and 20 µM
3-MB-PP1 (left kinase assay) or solvent alone (right kinase assay) was
added after the first division at t = 180. (c,d) Fin1 immunoprecipitates
from asynchronous skp1.A4 (c) or cell-size-selected sid2.as4 skp1.A4 (d)
cultures were split in two and probed with antibodies that recognize the
indicated phosphorylation sites or polyclonal antibodies that recognize the
non-catalytic domain of Fin1. See Supplementary Fig. S3g for details of
the scheme used for each of the three identical cultures used to generate
the samples and Supplementary Fig. 3h for the phenotypic characterization
of one of the three cultures. Samples from asynchronous cultures are run
in the left lane in each case to provide a reference standard. (e) Sid2
immunoprecipitates were isolated from asynchronous cultures and employed
in in vitro kinase assays using [γ−32P]ATP and either recombinant Fin1.KD
or casein as indicated. (f) Sid2 was isolated from the indicated strains and
combined with recombinant Fin1.KDnHis before blotting with the indicated
antibodies. (g) The incorporation of 32P into casein from [γ−32 P]ATP was
used to monitor Sid2 activity in size-selected wild-type cultures. (h) Sid2
immunoprecipitates were processed as for g with the exception that the
shorter Fin1.FP1 (non-catalytic carboxy-terminal domain20) was used as a
substrate and the F1S698P antibody was used to develop the assay with the
secondary reagent BCIP. The loading of the Sid2.250 36 ◦C sample in the
second to last lane was four times that in other lanes to ensure that the basal
level dictated by the reduced level of Sid2.250 protein in the 36 ◦C sample
was representative of the reference point for normalization. (g,h) Plots show
the activity per unit protein (that is, specific activity).
740 NATURE CELL BIOLOGY VOLUME 14 | NUMBER 7 | JULY 2012
© 2012 Macmillan Publishers Limited.  All rights reserved. 
 
L E T T ERS
260 300 340 380 420 460 500
S
ep
ta
tio
n 
in
d
ex
 (%
)
Time (min)
H
is
to
ne
 H
3 
p
os
iti
ve
 c
el
ls
 (%
)
S
ep
ta
tio
n 
in
d
ex
 (%
)
Time (min)
H
is
to
ne
 H
3 
p
os
iti
ve
 c
el
ls
 (%
)
Time (min)
M
ito
tic
 in
d
ex
 (%
)
260 300 340 380 420 460 500
B
in
uc
le
at
e 
ce
lls
 (%
)
Time (min)
260 300 340 380 420
M
ito
tic
 in
d
ex
 (%
)
Time (min)
Untreated Methanol 3MB-PP1
sid2.as4 
M
ito
tic
 in
d
ex
 (%
)
Time (h)
a d
b
c
20 µM 3MB-PP1
Wild type
sid2.as4 
fin1.as3 
0 1 2 3 4 5
0
1
2
3
4
5
6
7
8
9
0
10
20
30
40
50
60
70
80
90
100
0
5
10
15
20
25
30
Time (min)
260 300 340 380 420
M
ito
tic
 in
d
ex
 (%
)
0
5
10
15
20
25
30
Time (min)
260 300 340 380 420
0
5
10
15
0
10
20
30
40
50
60
70
260 300 340 380 420 460 500
0
10
20
30
40
50
260 300 340 380 420
0
5
10
15
Time (min)
260 300 340 380 420
0
5
10
15
20
25
Wild type
fin1.as3
Figure 3 Inhibition of Sid2 or Fin1 delays mitotic commitment. (a) 3-MB-PP1
was added to asynchronous cultures of wild-type, fin1.as3 and sid2.as4 cells,
and the mitotic index monitored by anti-α-tubulin immunofluorescence at the
indicated times. The analogue transiently inhibited mitotic commitment of
fin1.as3 and sid2.as4 but not wild-type cells. (b–d) Wild-type, fin1.as3 and
sid2.as4 cultures were synchronized with respect to cell cycle progression
by size selection and split into three equal cultures after the first round of
septation. Methanol or 3-MB-PP1 (to a final concentration of 20 µM) in
methanol was added to two of these sub-cultures at 160min. Commitment
to mitosis was monitored by the spindle index or phospho-histone H3
reactivity, as indicated. Addition of solvent alone had no impact on
cell cycle progression whereas addition of analogue in solvent delayed
mitotic commitment in fin1.as3 and sid2.as4 cells, but had no impact on
wild-type cells.
Fin1 (Ser 377 (RVTS) and Ser 526 (RKVS)) are phosphorylated in vivo
(Supplementary Fig. S3c–e). Antibodies that specifically recognize each
site when phosphorylated (F1S377P, F1S526P) recognized Fin1 that
had been immunoprecipitated from skp1.A4 cells grown at 36 ◦C, but
failed to do so when the precipitate had been treated with λ phosphatase
(Fig. 2c). Their ability to recognize Fin1 precipitated from mid/late G2
phase sid2.as4 skp1.A4 cells was dependent on Sid2 activity (Fig. 2d and
Supplementary Fig. S3g,h).
Polyclonal antibodies against the non-catalytic domain of Sid2
(Supplementary Fig. S2m)were used for in vitro Sid2 kinase assays using
either casein or His-tagged Fin1.KD as the in vitro substrate (Fig. 2e
and Supplementary Fig. S2k,n). Both Ser 377 and Ser 526 of Fin1.KD
(Fig. 2f, lanes 3–6) were phosphorylated by Sid2 immunoprecipitates;
this activity was temperature dependent when Sid2 had been isolated
from sid2.250 cultures (Fig. 2f, lanes 1 and 2). Addition of 3-MB-PP1
to the analogue-sensitive kinase precipitated from sid2.as4 cells also
abolished activity towards each site (Fig. 2f, lanes 7 and 8). The
continued fluctuation of Fin1.S377AS526A levels during cell cycle
progression (Supplementary Fig. S3i) suggested that Sid2 might
phosphorylate additional sites on Fin1. Consistently, Ser 698 was
phosphorylated in mass spectra of recombinant Fin1.KD that had been
incubated with Sid2 in vitro and in spectra of Fin1 precipitated from
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Table 1 Cell length measurements support the model depicted in Fig. 4h.
Cell length at division Cell length at division following treatment with ATP analogues
Cell length in
micrometres
Cell length in
micrometres
Anaphase cells Septating cells
Wild type, 36 ◦C, 2 h 13.0±1.7 Wild type
fin1.∆, 36 ◦C, 2 h 14.0±2.1 Untreated 12.5±1.8
sid2.250, 36 ◦C, 2 h 15.6±2.2 3-MB-PP1, 2 h 12.4±1.3
Septating cells 3-MB-PP1, 4 h 12.8±1.3
Wild type 12.5±1.8 3-MB-PP1, 8 h 12.3±1.0
fin1.∆ 13.3±2.0 fin1.as3
fin1.K33R 15.0±2.2 Untreated 13.8±1.4
fin1.KD 15.9±1.6 3-MB-PP1, 2 h 13.2±1.0
fin1.S698A 13.9±1.3 3-MB-PP1, 4 h 15.2±1.8
fin1.S698E 12.5±1.3 3-MB-PP1, 8 h 15.7±1.0
fin1.2A 12.9±1.4 fin1.as3 cdc2.1w
fin1.2E 12.8±1.2 Untreated 7.7±0.9
fin1.3A 14.9±1.9 3-MB-PP1, 2 h 7.8±0.8
fin1.3E 11.7±1.7 3-MB-PP1, 4 h 8.2±0.9
cdc2.1w 7.9±0.9 3-MB-PP1, 8 h 8.0±0.9
fin1.∆ cdc2.1w 8.1±1.5 fin1.as3 cdc2.3w
fin1.KD cdc2.1w 8.1±0.7 Untreated 10.8±1.1
cdc2.3w 8.0±1.4 3-MB-PP1, 2 h 11.0±1.2
fin1.∆ cdc2.3w 10.7±2.8 3-MB-PP1, 4 h 11.9±1.4
fin1.KD cdc2.3w 11.3±4.0 3-MB-PP1, 8 h 12.0±1.5
pom1.∆ 11.1±1.0 fin1.as3 pom1.∆
pom1.∆fin1.KD 11.4±1.9 Untreated 11.5±1.4
pom1.∆fin1.3A 11.0±1.4 3-MB-PP1, 2 h 11.6±1.6
pom1.∆fin1.3E 10.9±1.8 3-MB-PP1, 4 h 12.0±1.6
cdr1.∆ 18.4±1.3 3-MB-PP1, 8 h 12.0±1.6
cdr1.∆fin1.KD 18.0±1.3 fin1.as3 cdr1.∆
cdr2.∆ 19.1±1.5 Untreated 17.3±1.1
cdr2.∆fin1.KD 19.3±1.3 3-MB-PP1, 2 h 17.4±1.6
fin1.3A cdr2.∆ 18.9±1.9 3-MB-PP1, 4 h 18.3±1.5
fin1.3E cdr2.∆ 18.4±2.3 3-MB-PP1, 8 h 18.2±1.6
fin1.as3 cdr2.∆
Untreated 19.4±1.4
3-MB-PP1, 2 h 19.9±1.2
3-MB-PP1, 4 h 21.1±1.6
3-MB-PP1, 8 h 20.2±1.6
fin1.as3 syncnhronous
420min 16.1±1.1
460min 17.5±1.1
580min 18.8±1.4
620min 18.9±1.2
For cell length at division, cells were grown in EMM2 medium to an attenuance of 0.1 at 595nm at 25 ◦C unless otherwise indicated and stained with either DAPI/calcofluor to identify anaphase
cells, or calcofluor alone to identify septating cells, as indicated. For cell length at division following treatment with 20 µM 3MB-PP1, cells were grown in EMM2 medium to an attenuance of
0.1 at 595nm at 25 ◦C and stained with calcofluor to identify septating cells.
skp1.A4 cells (Supplementary Fig. S3f). Although the context of Ser 698
(LPGS) does not conform to the RXXS/T consensus5, we note that
the analogous budding yeast kinase, Dbf2, also phosphorylates sites
that deviate from this in vitro-defined consensus7. The recognition of
Fin1 by antibodies that specifically recognize phosphorylated Ser 698
(F1S698P) mirrored the in vitro and in vivo dependency on Sid2
function exhibited by F1S377P and F1S526P (Fig. 2c,d,f), indicating
that Ser 698 is directly phosphorylated by Sid2 in G2 phase. Integration
of the triply mutated fin1.S377AS526AS698A (fin1.3A) allele at the
fin1 locus generated a protein whose levels remained constant as
cells transited the cell cycle (Supplementary Fig. S3j), supporting the
view that direct phosphorylation of all three sites by Sid2 regulates
Fin1 activity in vivo.
We quantified the cell-cycle-dependent variation in Sid2 activity
by using either 32P incorporation into casein or F1698P reactivity of
Fin1.KD (Fig. 2g,h). The signal from Sid2 precipitated from sid2.250
cells that had been incubated at the restrictive temperature of 36 ◦C
defined the baseline level of activity in each assay. Sid2 specific activity
in size-selected synchronous cultures increased significantly following
mitotic commitment. Importantly, whereas the activity did not exceed
that of the Sid2.250 control early inG2 (Fig. 2g, t =180 and 200; Fig. 2h,
t = 220 and t = 230), it did in the later stages (Fig. 2g,h; compare
sid2.250 lanes with: 220–280 (Fig. 2g) and 240–280 (Fig. 2h)). We
conclude that Sid2 activity towards Fin1 appears in G2 phase before
being considerably enhanced during mitosis.
We addressed the functional significance of Fin1 activation by Sid2 in
G2 phase by exploiting our ability to inhibit Fin1.as3 (Supplementary
Fig. S2e–g) and Sid2.as4 (Supplementary Fig. S2h–l) function with
the ATP analogue 3-MB-PP1. Analogue addition to asynchronous
sid2.as4 or fin1.as3 cultures prompted an immediate, but transient,
decline in mitotic index (Fig. 3a). Cell size at division increased during
the recovery from this transient G2 arrest (Table 1), indicating that
inhibition of Sid2 or Fin1 delayed the timing of mitotic commitment
until a new size threshold for division was met. Addition of analogue
to size-selected wild-type cultures immediately after completion of
the first synchronous division had little impact on the timing of the
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Figure 4 Sid2 and Fin1 target Cdr1/Cdr2/Pom1 to control mitotic
commitment through Wee1. (a) Schematic detailing the analogue wash-out
approach. (b–f) 5 h after the addition of 3-MB-PP1 to early log-phase
cultures of the indicated strains cells were filtered from the culture and
re-suspended at the same density in growth medium that contained
no inhibitor. Restoration of Sid2 and Fin1 function induced a burst
of mitosis. Importantly, restoration of Sid2 function failed to induce
mitotic commitment when Fin1 kinase was inactivated by the fin1.KD
mutations (b). (c) Restoring Sid2 activity in strains harbouring mutation of
the candidate Sid2 phosphorylation sites in Fin1 suggests that Sid2 can
activate Fin1 by phosphorylating the serine at either 377, 526 or 698. Both
Sid2 and Fin1 were able to induce mitosis when the cdc2.3w mutation
compromised sensitivity to Cdc25, but not when the cdc2.1w mutation
compromised Wee1 inhibition of Cdc2 (d), or the functions of Pom1,
Cdr1 or Cdr2 are ablated (e,f). (g) Pom1.GFP signals in the indicated
strain backgrounds. (h) A schematic depicting the model for G2/M
control by Sid2/Fin1. P represents phosphorylation, and Ub represents
ubiquitin conjugation. Fin1 is activated in G2 by phosphorylation by Sid2.
This promotes mitotic commitment through modulation of the geometry
network; however, the exact mechanism remains to be determined.
Activated Fin1 promotes its own destruction, thereby limiting its activity
temporally. Our present lack of understanding of the means by which Fin1
regulates the Pom1/Cdr1/Cdr2/Wee1 cell geometry network is represented
by incorporating all members of this pathway that are required for Fin1 to
regulate mitotic commitment within a single rectangle. The question mark
to the left of this rectangle reflects our lack of knowledge as to whether
it is the Sid2 or the auto-phosphorylated form of Fin1 that is responsible
for the control of the cell geometry network. The question mark beneath
Sid1–Cdc14 reflects our ignorance as to the nature of the cue in G2 phase
that triggers this pathway. See main text for further details.
subsequent mitosis (Fig. 3b). In contrast it delayed the appearance
of mitotic spindles in both fin1.as3 and sid2.as4 cells (Fig. 3c,d).
Importantly, the length of septating fin1.as3 cells increased following
analogue addition (Table 1), confirming that the delayed appearance
of mitotic cells represented a true delay in mitotic commitment rather
than an impact on growth rate.
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Neither Fin1 nor Sid2 is essential for mitotic progression at 25 ◦C. If
Sid2 activation of Fin1 promotes mitotic commitment, inhibition of
either kinase would create a population of late G2 cells that had grown
beyond the point in G2 at which the kinase normally promotes mitotic
commitment. Restoration of kinase activity to those cells that occupy
this newly created ‘permissive’ window within the extended G2 would
be expected to promote immediate entry of this cohort into mitosis,
resulting in a synchronized wave of division (Fig. 4a). We therefore
transiently inhibited each kinase by analogue addition before restoring
activity by filtration and resuspension into fresh medium devoid of
analogue one generation time later. In each case restoration of kinase
activity was followed by a peak of mitotic cells (Fig. 4b) confirming
that each kinase promotes mitotic commitment.
Further analogue wash-out experiments enabled us to draw two
important conclusions about the relationship between Sid2 and Fin1.
First, Fin1 seems to be the main target for Sid2 kinase in mitotic
commitment control because inactivation of Fin1 abolished the
burst of mitosis in a sid2.as4 fin1.KD analogue wash-out experiment
(Fig. 4b). Second, the Sid2/Fin1 switch is very responsive to Sid2
activity, because phosphorylation of either 698 alone or 377 and 526
promotes mitosis (Fig. 4c).
Next, we examined whether Sid2/Fin1 signalling targeted the
maturation-promoting factor regulators Wee1 and Cdc25, by
exploiting two well-characterized cdc2 mutations; cdc2.3w mutants
are largely insensitive to Cdc25 (ref. 8) whereas cdc2.1w cells are largely
insensitive to Wee1 (refs 9,10). The peaks of mitosis arising from
reactivation of either Sid2 or Fin1 were abolished by cdc2.1w but
not cdc2.3w (Fig. 4d), suggesting an exclusive routing through Wee1.
Consistently, wee1.∆ also blocked the mitotic induction in analogue
wash-out experiments (data not shown).
Pom1 kinase controls the timing of mitotic commitment by
regulating the inhibitory impact of Cdr1/Cdr2 on Wee1 activity11–14.
pom1.∆, pom1.2, cdr1.∆ or cdr2.∆ (but not blt1.∆, data not shown)
mutationsmimicked cdc2.1w in blocking the wave of mitosis (Fig. 4e,f),
indicating that the Sid2/Fin1 switch regulatesWee1 through Pom1. The
means by which it does so awaits further analysis; however, we note that
Pom1 remained at the tips of fin1.KD or fin1.∆ cells (Fig. 4g).
In S. pombe, there is a direct correlation between cell length at
septation and the timing of mitotic commitment15. Blocking Fin1
function by mutational or chemical ablation of kinase activity, or gene
deletion, increased cell length at septation, indicating a delay in mitotic
commitment (Table 1). Blocking Sid2 function with the sid2.250
mutation similarly delayed mitotic commitment at 36 ◦C (Table 1).
Mutations that either blocked, or mimicked, phosphorylation of Fin1
by Sid2, increased or reduced cell length at division, respectively
(Table 1). Importantly, loss of function of any of the proteins predicted
by the analogue wash-out experiments to act after Fin1 either
abolished the delay to mitotic commitment arising from deletion of
fin1+ (pom1.∆,cdc2.1w) or were not additive with it (cdr1.∆,cdr2.∆),
confirming that Fin1 relies on Pom1 control of Cdr1/Cdr2 to modulate
Wee1 activity (Table 1).
In summary, we believe that activation of Sid2 midway through
G2 phase phosphorylates Ser 377, Ser 526 and Ser 698 of Fin1. Fin1
activation has two consequences: Fin1 destruction and the promotion
of mitotic commitment through the Pom1/Cdr1/Cdr2/Wee1 cell
geometry network (Fig. 4h).
Although Sid2–Mob1 kinase is a well-characterized SIN
component1,16, three arguments suggest that the population of
Sid2/Mob1 that drives the G2 control of Fin1 is not operating
within the context of the SIN. First, restoration of Sid2 activity in
analogue wash-out experiments promoted a burst of mitosis when
SIN function was ablated in sid4.SA1 and cdc11.136 cells at 36 ◦C
(Supplementary Fig. S4a,b). Second, cycles of Fin1 accumulation
and destruction persisted in synchronized cultures when SIN activity
was abolished by the mutations cdc11.136 and cdc7.A20 spg1.B8
(Supplementary Fig. S4c–e). In sid4.SA1 cultures, Fin1 destruction
in G2 persisted; however, the mitotic accumulation of Fin1 was
perturbed (Supplementary Fig. S4f). Finally, induction of SIN
signalling by inactivation of Cdc16 (ref. 17) did not promote Fin1
destruction (Supplementary Fig. S4g). The impact of conditional
mutations in Sid1–Cdc14 kinase were more complex as it is required
for the accumulation and degradation of Fin1 in early G2 phase
(Supplementary Fig. S4h,i). This would suggest that the tight
relationship proposed for Sid1 activation of Sid2 in the SIN may
also couple the functions of these kinases in the control of Sid2 in
G2 (ref. 18). Whereas the Fin1 profile of sid1.c14 cells shows only a
marginal decline in Fin levels, the data for the cdc14.332 strain, which is
more easily synchronized by size selection, clearly show persistence of
Fin1 destruction at the end ofmitosis (Supplementary Fig. S4i).
As the diffuse distribution of Fin1 during G2 phase contrasts with
the association of Sid2.GFP with the spindle pole body16,19 (SPB) at
this time, we used the polyclonal Sid2 antibodies to re-examine the
distribution of Sid2. Unlike the Sid2.GFP fusion protein, wild-type,
untagged, Sid2 did not associate with interphase SPBs (Supplementary
Fig. S5a,b), even though Sid2 was present at this stage of the cell
cycle (Supplementary Fig. S5c). Thus, it is a cytoplasmic population
of Sid2 that is activated midway through G2 to regulate a cytoplasmic
population of Fin1. We assume that Fin1 activity in an individual cell
in G2 is transient because Fin1 activation promotes its own destruction.
When this control is missing, G2 phase is extended by 50%. This role for
Fin1 in promoting mitotic commitment through Pom1/Cdr1/Cdr2 is
distinct from its role in regulating Plo1 recruitment to the SPB (ref. 20),
as the plo1.S402Amutation that perturbs the latter21 had no impact on
the ability of Fin1 or Sid2 to promote mitotic commitment in analogue
wash-out experiments (data not shown). The timing of Sid2/Fin1
activation is strikingly reminiscent of the point in G2 phase proposed
when an invariant timer is triggered by the completion of the variable
sizer to commence preparations for mitotic commitment22. Thus,
mitotic commitment in fission yeast may be more similar to the staged
antephase/mitotic commitment of mammalian somatic cells than the
rapid transitions seen in Xenopus or sea urchin oocyte systems23. 
METHODS
Methods and any associated references are available in the online
version of the paper at www.nature.com/naturecellbiology
Note: Supplementary Information is available on the Nature Cell Biology website
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METHODS
Cell culture and growth. The strains used in this study are listed in Supplementary
Table S1. Cells were grown and maintained according to ref.24. Appropriately
supplemented EMM2 synthetic medium was used for all experiments, except
cell length measurements, which were conducted with prototrophic strains in
unsupplemented EMM2. Centrifugal elutriation was used to isolate small G2 cells25.
ATP analogues (Toronto Research Chemicals) were dissolved in methanol to
generate 50mM stock solutions that were subsequently added to cultures. For all
data presented outwith Supplementary Fig. S2, 3-MB-PP1 at a final concentration
of 20 µM(0.04%methanol of total culture volume) was used to inhibit Sid2.as4 and
Fin1.as3 function.
Microscopy and fluorescence-activated cell sorting analysis. Anti-
tubulin/Sad1, anti-Sid2 and anti-histone H3 phospho-serine 10 immunofluores-
cence and calcofluor staining were conducted using established procedures after
antibody dilution: TAT1 1:80, AP9.2 Sad1 1:25, Sid2 1:100 and phospho-histone
H3 1:100 (refs 15,26,27). For Sid2 fluorescence, fixation for 10min with 3%
formaldehyde was used for optimal SPB staining, and the duration of this fixation
period was extended to 30min to give optimal preservation of the signal on the
cytokinetic ring28. DNA content through fluorescence-activated cell sorting analysis
used Cytox green (Invitrogen) according to published procedures29.
Genetic manipulation, fusion protein production and antibody generation.
Mutant alleles were generated by QuikChange mutagenesis (Stratagene) and
inserted into the genome with the marker switch approach using natMX6 as a
marker30 (Supplementary Fig. S2). The Sid2 sheep polyclonal antibody was raised
by the Scottish National Blood Transfusion Service against recombinant Sid21−205
that had been purified from Escherichia coli. Rabbit polyclonal antibodies against
histoneH3 Ser 10 and peptides corresponding to the sequences surrounding Ser 377,
Ser 526 and Ser 698 in which these serines were phosphorylated were generated by
Eurogentec. The generation and purification of Fin1 polyclonal antibodies has been
described previously19. Recombinant Fin1.KDn6His was purified from E. coli.
Immunoblotting and kinase assays. To monitor Fin1 levels, all blots were cut
in half, one half developed with anti-Fin1 antibodies and the other with PN24
antibodies that recognize Cdc219,31. Blots were developed with BCIP and scanned or
developed with ECF (Amersham) and imaged with a Pharos FX Molecular Imager
(BioRad). Identical profiles were obtained when fluorescent antibodies were used
rather than BCIP as a substrate for the secondary antibody (compare Fig. 1a with
Supplementary Fig. S1a). Blots were quantified using ImageJ. A mask was drawn
around each band on the blot. The total counts were recorded when the mask was
both over the band and again immediately below it, in the blank region of the lane.
Subtraction of the second value from the first gave the protein level. In all cases,
Fin1 levels were normalized to those of Cdc2 in the same lane on the same blot.
The level of Fin1 observed immediately after elution of wild-type cells was set at 1
and all other levels were quantified relative to this basal level. For western blotting,
Fin1, Sid2 and Cdc2 antibodies were used at a dilution of 1:500; the three phospho-
specific antibodies were used at a dilution of 1:20. For immunoprecipitations, 15 µl
Dynabeads A (Invitrogen, 100.02D) was loaded with 1.5 µl Fin1 or Sid2 undiluted
antibody and used as per the manufacturer’s instructions.
For the kinase assays, Fin1/Sid2was precipitated from2×108 cells with polyclonal
antibodies with Dynabeads A (Invitrogen) in KA buffer: 50mM HEPES, 10mM
EDTA, 40mM Na-β-glycPhosh, 4mM Na3VO4, 50mM NaF, 0.6% NP40, 150mM
NaCl, protease inhibitor cocktail (Roche) and 1mM phenylmethylsulphonyl
fluoride. The kinase reaction was carried out at 30 ◦C for 30min in KR buffer:
20mMHEPES, 15mMKCl, 1mM EGTA, 10mMMgCl2, 10mMMnCl2, 0.125 nM
ATP and 10 µg of either recombinant Fin1.KDn6His (Fig. 2a–d and Supplementary
Fig. S2b,d,k,n) casein (Figs 1f and 2e,g) or Fin1FP1 (ref. 19) (Fig. 2h). For assessment
through 32P incorporation, 5 µCi[γ −32 P]ATP was also added to the reaction
mix. The amount of 32P incorporated into the substrate was determined with a
Phosphorimager (BioRad).
To identify in vivo phosphorylation sites on Fin1, the protein was precipitated
from 2× 1011 skp1.A4 cells with polyclonal α-Fin1 antibodies. To identify in vitro
Sid2-phosphorylation sites on Fin1, a Sid2 kinase assay was carried out as described
in the previous paragraph using 50 µg recombinant Fin1.KDn6His as a substrate
having isolated Sid2 from 6×108 cells. The Fin1.KD protein was isolated from the
reaction mix using Ni-magnetic beads (Qiagen) before mass spectrometry.
Mass spectrometry. Samples were run on 4–12% NuPAGE bis-Tris gel (Invit-
rogen); Fin1 bands were excised and digested with either 20 ng sequencing-grade
trypsin (Sigma-Aldrich), 400 ng LysN (Associates of Cape Cod) or 350 ng elastase
(Calbiochem) in 100 µl 40mM ammonium bicarbonate with 9% (v/v) acetonitrile
at 37 ◦C for 18 h. The peptides were separated using a Nano-Acquity UPLC system
(Waters) using a Waters NanoAcquity BEH C18 column (75 µm inner diameter,
1.7 µm, 25 cm) with a gradient of 1–25% (v/v) of acetonitrile with 0.1% formic acid
over 30min at a flow rate of 400 nlmin−1.
The LTQ-Orbitrap XL mass spectrometer was operated in parallel data-
dependent mode where the mass spectrometry survey scan was performed at
a nominal resolution of 60,000 (at m/z 400) in the Orbitrap analyser over an
m/z range of 400–2,000. The top 6 precursors were selected for collision-induced
dissociation in the LTQ at a normalized collision energy of 35% using multi-stage
activation atm/z 98.0, 49.0 and 32.7Da.
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Figure S1 Fin1 levels; protein blot data. a)  Fin1 levels were normalised 
to the level of Cdc2 kinase in the same lane on the same blot and plotted 
against time as cells transit the cell cycle. Fin1 was destroyed twice as 
wild type cells transited the cell cycle; mid-G2 (Grey arrow: G) and during 
septation (open arrow: C). The blot used to generate the plot is shown below 
the graph. This blot was developed with the fluorescent substrate ECF, while 
those for all other synchronised cultures in this manuscript were performed 
with the chromogenic substrate BCIP.  The profile in a) is indistinguishable 
from the plot in Figure 1a in which BCIP was used to develop the blot.  b) 
The blots that were quantified to generate the data shown in the indicated 
figures. (c) Fin1 levels and septation profiles of the portions of the culture 
shown in in Figure 1i that received no treatment (left) or to which an 
equivalent volume of methanol had been added to that bearing 3-MB-PP1 in 
Figure 1i.
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Figure S2 Fin1and Sid2 reagents and the impact of ATP analogues upon 
cell cycle progression. a-g) Fin1 reagents. a-d) fin1.K33RN165A encodes a 
catalytically inactive protein. a) A cartoon of the construct used to integrate 
fin1 mutant alleles at the native locus indicating the location of the residues 
within the catalytic domain that were mutated to abolish kinase activity 
(K33, N165) or generate analogue sensitive alleles (M82, G168).  The 
selection of the two sites for kinase inactivation was based upon the previous 
work in many labs that has established that point mutation of either the 
conserved lysine in domain II to arginine or the asparagine of domain VIB 
to alanine severely compromises kinase activity1. b) Fin1 kinase assays in 
which the activity of wild type Fin1 and Fin1.K33R or Fin1.K33RN165A 
mutant proteins against casein is assessed. c) The spindle formation defect 
after 3 hours at 37°C of the double fin1.K33RN165A mutant was greater 
than that of the single fin1.K33R.   Similarly Fin1 protein accumulated to 
a greater extent in fin1.K33RN165A than in fin1.K33R cells (Figure 1c). 
Finally, cell length measurements indicate a greater defect in the double 
fin1.K33RN165A than single fin1.K33R mutant (Table 1).  We conclude 
that the fin1.K33RN165A allele encodes a catalytically inactive molecule 
and is therefore referred to as fin1.KD (for kinase dead) throughout the 
manuscript. d) Fin1 kinase assays in which the catalytically inactivated 
Fin1 substrate is mixed with immunoprecipitates from the indicated strains; 
the substrate on it’s own possesses no intrinsic kinase activity. e) A graph 
scoring the frequency of abnormal mitoses 3h following addition of analogue 
to the fin1.asx alleles indicated.  f) Fin1 levels following normalisation to 
control Cdc2 protein levels in the indicated strains 3 hours after the addition 
of the indicated ATP analogues to early log phase cultures at 25°C and 
36°C. g) A table showing the mutation sites and phenotypes of the different 
fin1.as alleles. (h-n) Sid2 reagents (h) A cartoon of the construct used 
to integrate sid2 alleles at the native locus indicating the location of the 
residues within the catalytic domain (M285, T348) that were selected for 
mutation to generate analogue sensitive alleles according to the published 
data from the Shokat lab2,3.  (i) Sid2 protein levels (normalised to those 
of Cdc2 in the same lane on the same blots) in the indicated strains after 
the indicated manipulations. (j) Plots of the indicated phenotypes at the 
times shown after the addition of the indicated ATP analogues or solvent 
alone to the indicated sid2.as alleles. (k) in vitro Sid2 kinase assays in 
which Sid2 immunoprecipitates from the indicated strains were used to 
phosphorylate casein with 32PgATP demonstrate that this assay specifically 
detects Sid2 kinase and no other activity. (l) A table showing the mutation 
sites and phenotypes of the different sid2.as alleles. (m) Characterisation 
of Sid2 antibodies. The slower migration of the band recognised by affinity 
purified Sid2 antibodies in wild type cells in a sid2.13myc background 
and the enhancement of the band upon induction of the expression of an 
integrated version of the sid2+ gene at the leu1 locus (leu1::nmt41sid2) 
indicates that these antibodies recognise the Sid2 protein. n) Sid2 kinase 
assays in which the catalytically inactivated Fin1 substrate is mixed with 
immunoprecipitates from the indicated strains. The right hand lane indicates 
that the substrate on it’s own possesses no intrinsic kinase activity under 
the reaction conditions used to monitor Sid2 activity.  o)  Impact of ATP 
analogue addition upon the septation profile of wild type cells.  A wild type 
culture was synchronised with respect to cell cycle progression by size 
selection and split into equal portions to which the indicated analogues were 
added at the indicated concentrations.  Septation was used as a read out 
of cell cycle progression.  While the timing of septation was perturbed by 
the addition of the indicated concentrations of 1-NA-PP1, 1-NM-PP1 and 
Bn-PP1 in this assay, 3-MB-PP1 had the least impact.  The modest impact 
of 20 mM MB upon the septation profile was not reproducible (see Figure 3) 
and probably arose because of the batch analysis approach in this extensive 
experiment. We therefore believe that in the assays used in this study had 
no impact upon the timing of mitotic commitment or the rate of mitotic 
progression. These specific conditions for which we believe this assertion 
holds true were the addition of 20 mM MB to asynchronous or size selected 
cultures grown to early log phase in the minimal medium EMM2 to which the 
supplements Leucine, Uracil, Adenine and Histidine had all been added to a 
final concentration of 200 mg ml-1.  It is likely that in other conditions such 
as live cell imaging where there are considerable levels of UV induced stress 
and conditions in many cases are anaerobic, different levels of sensitivity 
may apply. 
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S3 Phosphorylation of S377, S526 and S698 of Fin1 by Sid2. The 
indicated strains were synchronised by size selection at 25°C. Each culture 
was split in two with one half shifted to 36°C while the other was maintained at 
25°C.  (a) For the sid2.as4 skp1.A4 mutant in panel a the shift was performed 
180 minutes after size selection and the ATP analogue 3MB-PP1 was added 
to a final concentration of 20 mM to each culture at this time. For the fin1.
KD skp1.A4 culture the shift was performed immediately after splitting the 
culture following size selection. (c-f)  Mass spectrometric analysis of Fin1 
phosphorylation sites.  (c, d) Product ion spectra from two independent elastase 
generated peptides (sequences denoted).  Product ions of particular analytical 
note are labelled with those fragments showing H3PO4 loss further denoted with 
*.  Both spectrum (c) and (d) confirm the respective sequences and location 
of the site of phosphorylation unambiguously as S377.  (e, f)  Product ion 
spectra from two LysN generated peptides.  Product ions of particular analytical 
note are labelled.   The spectrum in panel (e) confirms the denoted sequence 
and the location of the site of phosphorylation unambiguously as S526.  The 
spectrum in (f) confirms the denoted sequence and the location of the site 
of phosphorylation unambiguously as S698. (g) A cartoon illustrating the 
procedure for sampling for the blots in Figure 2d.  Small G2 cells were isolated 
by centrifugal elutriation. After one round of division the culture was split into 
two and the ATP analogue 3-MB-PP1 in MeOH or the solvent alone were added. 
30 minutes later Fin1 was isolated by immunoprecipitation and probed with 
the phospho-specific and generic Fin1 antibodies to give the blots shown in 
Figure 2d. (h).  The phenotypic characterisation of one of the three cultures 
used to create the samples for panel d of Figure 2d. (i-j)  Fin1 protein levels as 
fin1.2A (i) or fin1.3A (j) cultures for which small G2 cells were isolated from 
asynchronous cultures at time 0.  While modest changes in Fin1.2A protein 
levels were observed, no changes were seen in Fin1.3A levels.
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S4 SIN function is not required to generate the cycles of Fin1 
accumulation/destruction. (a, b) “Analogue washout” experiments as 
executed for Figure 4b-f with the indicated strains.  Restoration of Sid2 
kinase activity was able to induce mitotic commitment in strains in which 
the function of the SIN anchor SPB protein Sid4 or the scaffold molecule 
Cdc11 had been compromised by conditional mutation.  The lack of 
induction in these backgrounds when Fin1 is catalytically inactive indicates 
that loss of either protein does not lead to a re-routing of the controls from 
Sid2 to another primary target. (c-f, h,i) Plots of Fin1 levels in size selected 
cultures of the indicated strains.  Culture were split into two after the first 
round of septation and one half was shifted to 36°C while the other was 
maintained at 25°C for the duration of the experiment (data not shown).  
Both phases of destruction were maintained in size selected wild type 
cultures (c). Perturbation of SIN function by mutation of the G protein/Pak 
kinase cassette Spg1/Cdc7 (d), the scaffold protein Cdc11 (e) or the SPB 
anchor protein Sid4 (f), had no impact upon the cycles in Fin1 levels. (g) 
SIN induction according to an approach detailed previously17.  Hydroxyurea 
was added to small G2 wild type or cdc16.116 cells 60 minutes after 
they had been isolated from an asynchronous population by centrifugal 
elutriation.  230 minutes later each culture was split into two and one half 
shifted to 36°C. This temperature shift inactivated the SIN inhibitor Cdc16 
driving SIN activation and consequently induced septation (grey triangles) 
in the S phase arrested cdc16.116 culture, but did not impact upon SIN 
function in the wild type control.  Fin1 levels were not altered by this form of 
ectopic induction of SIN activity. Sid1 (h) and Cdc14 (i) are required for the 
G2 phase accumulation and destruction of Fin1.
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S5 Sid2 recruitment to mitotic but not interphase SPBs. a, b, d, e)  
Sid2 immunofluorescence/DAPI/combined DAPI and differential interference 
contrast (DIC) images of the indicated strains.  For all panels in the figure 
the “SPB fix” (10 mins 3% formaldehyde) was used with the exception of 
the indicated panel in (a) where “ring fix” (30 mins 3% formaldehyde) was 
employed.  For (b) the immunofluorescence imaging combined Sid2 and 
Sad1 imaging as indicated to show that the Sid2 signal was absent from 
short, uninucleate, G2 cells in which a clear Sad1 signal could be detected.  
(a) In addition to staining of the cytokinetic ring, the Sid2 signal was seen 
on the mitotic SPBs of sid2+ and sid2.c13myc cells.  In contrast, the ring 
staining was accompanied by association with the SPBs irrespective of cell 
cycle status in the sid2.GFP background. We conclude that the finding 
that Sid2 is recruited to SPBs throughout the cell cycle16 is misleading as 
it is based upon a behavioural shift in the Sid2.GFP fusion protein that is 
generated by the addition of the GFP sequences.  Rather we suggest that 
Sid2 binds to SPBs of mitotic cells from just after the separation of the two 
SPBs following mitotic commitment until the degradation of the septum 
(staining persists on the SPBs while the background fluorescence in cells 
indicates that the primary septum is full formed). (c) Sid2 levels in western 
blots of whole cell extracts (right panel) remain constant as cells transit 
the cell division cycle (left).  (d) Sid2 immunofluorescence of cdc10.v50, 
cdc25.22 or nda3.KM311 cells after, 5, 4.5 or 9 hours at their restrictive 
temperatures, respectively, consolidates the view that Sid2 only associates 
with the SPBs during mitosis (nda3.KM311), but neither G1 (cdc10.
v50) nor G2 (cdc25.22) phase of the cell cycle.  We conclude that Sid2 
associates with mitotic but not interphase SPBs and that this association 
with the SPB is regulated at the level of recruitment and not synthesis/
stability.  (e) Given that the fusion of GFP to Sid2 kinase influences it’s 
recruitment to the SPB we assessed the dependency of the wild type (Sid2+) 
protein upon the function of the SPB anchor and SIN scaffold molecules 
Sid4 and Cdc11.  Like Sid2.GFP, wild type Sid2+ relies upon these 
molecules to dock to the SPB. 
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